Perrig Melina Soledad, Veaute Carolina, Renna María Sol, Pujato Nazarena, Calvinho Luis, Marcipar Iván, Barbagelata María Sol
Laboratorio de Tecnología Inmunológica, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, RN168, Ciudad Universitaria, Santa Fe, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Argentina.
Laboratorio de Tecnología Inmunológica, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, RN168, Ciudad Universitaria, Santa Fe, Argentina.
Microb Pathog. 2017 Apr;105:273-279. doi: 10.1016/j.micpath.2017.02.035. Epub 2017 Mar 1.
Streptococcus uberis is one of the most prevalent pathogens causing clinical and subclinical mastitis worldwide. Among bacterial factors involved in intramammary infections caused by this organism, S. uberis adhesion molecule (SUAM) is one of the main virulence factors identified. This molecule is involved in S. uberis internalization to mammary epithelial cells through lactoferrin (Lf) binding. The objective of this study was to evaluate SUAM properties as a potential subunit vaccine component for prevention of S. uberis mastitis. B epitope prediction analysis of SUAM sequence was used to identify potentially immunogenic regions. Since these regions were detected all along the gene, this criterion did not allow selecting a specific region as a potential immunogen. Hence, four fractions of SUAM (-1fr, 2fr, 3fr and 4fr), comprising most of the protein, were cloned and expressed. Every fraction elicited a humoral immune response in mice as predicted by bioinformatics analysis. SUAM-1fr generated antibodies with the highest recognition ability towards SUAM native protein. Moreover, antibodies against SUAM-1fr produced the highest proportion of internalization inhibition of S. uberis to mammary epithelial cells. In conclusion, SUAM immunogenic and functionally relevant regions were identified and allowed to propose SUAM-1fr as a potential candidate for a subunit vaccine for S. uberis mastitis prevention.
乳房链球菌是全球范围内引起临床和亚临床乳腺炎的最常见病原体之一。在该病原体引起的乳腺感染所涉及的细菌因素中,乳房链球菌粘附分子(SUAM)是已确定的主要毒力因子之一。该分子通过与乳铁蛋白(Lf)结合参与乳房链球菌内化至乳腺上皮细胞的过程。本研究的目的是评估SUAM作为预防乳房链球菌乳腺炎的潜在亚单位疫苗成分的特性。对SUAM序列进行B表位预测分析以鉴定潜在的免疫原性区域。由于这些区域在整个基因中均被检测到,因此该标准无法选择特定区域作为潜在免疫原。因此,克隆并表达了包含该蛋白质大部分的SUAM的四个片段(-1fr、2fr、3fr和4fr)。如生物信息学分析所预测的,每个片段在小鼠中均引发了体液免疫反应。SUAM-1fr产生的抗体对SUAM天然蛋白具有最高的识别能力。此外,针对SUAM-1fr的抗体对乳房链球菌内化至乳腺上皮细胞的抑制比例最高。总之,已鉴定出SUAM的免疫原性和功能相关区域,并提出SUAM-1fr作为预防乳房链球菌乳腺炎的亚单位疫苗的潜在候选物。